Pricing Log in Create free account

Jazz Pharmaceuticals PLC (JAZZ) vs Twist Bioscience Corporation (TWST)

Jazz Pharmaceuticals PLC and Twist Bioscience Corporation are both Biotechnology companies. Jazz Pharmaceuticals PLC is the larger, with a market value of $14.0B against $10.1B — 1.4× the size. Twist Bioscience Corporation has negative trailing earnings, so its P/E is not meaningful; Jazz Pharmaceuticals PLC trades at 14.2×. Twist Bioscience Corporation grew revenue faster over the last twelve months: 19.2% against 12.6%. Jazz Pharmaceuticals PLC has the higher net margin (20.5% vs −31.7%) and the higher return on invested capital (8.06% vs −30.8%). Across the 18 metrics below, Jazz Pharmaceuticals PLC leads on 12 and Twist Bioscience Corporation on 6.

Valuation

Metric JAZZ TWST Biotechnology median
P/E 14.16 n/m 12.43
P/S 2.97 22.08 10.53
P/B 2.84 21.39 2.24
Price to free cash flow 9.64 n/m 22.59
EV/EBITDA 9.79 n/m 0.69
EV/Sales 3.43 21.73 9.92
Earnings yield 7.06% (1.45%) (34.94%)
Free cash flow yield 10.38% (1.00%) (23.17%)

Profitability

Metric JAZZ TWST Biotechnology median
Gross margin 88.42% 51.97% 68.94%
Operating margin 19.49% (33.58%) 0.00%
Net margin 20.45% (31.66%) 0.00%
Free cash flow margin 30.79% (22.15%) 0.00%
Return on equity 22.11% (29.59%) (54.09%)
Return on assets 8.54% (20.78%) (46.84%)
Return on invested capital 8.06% (30.83%) 0.00%

Growth

Metric JAZZ TWST Biotechnology median
Revenue growth (TTM) 12.59% 19.19% 6.72%
EPS growth (last fiscal year) (167.51%) 63.89% 29.36%
Revenue growth, 5-year CAGR 12.54% 33.11% 9.96%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JAZZ TWST Biotechnology median
Debt to equity 0.91 0.03 0.00
Current ratio 1.78 2.67 5.00
Net debt to EBITDA 10.96 1.95 1.01

Dividend

Metric JAZZ TWST Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric JAZZ TWST Biotechnology median
Market cap 14.02b 10.06b 177.44m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack